Live Updates: COVID-19 Cases
  • World 20,827,512
    World
    Confirmed: 20,827,512
    Active: 6,356,561
    Recovered: 13,723,368
    Death: 747,583
  • USA 5,360,302
    USA
    Confirmed: 5,360,302
    Active: 2,378,568
    Recovered: 2,812,603
    Death: 169,131
  • Brazil 3,170,474
    Brazil
    Confirmed: 3,170,474
    Active: 756,734
    Recovered: 2,309,477
    Death: 104,263
  • India 2,399,992
    India
    Confirmed: 2,399,992
    Active: 655,012
    Recovered: 1,697,811
    Death: 47,169
  • Russia 907,758
    Russia
    Confirmed: 907,758
    Active: 175,978
    Recovered: 716,396
    Death: 15,384
  • South Africa 568,919
    South Africa
    Confirmed: 568,919
    Active: 125,880
    Recovered: 432,029
    Death: 11,010
  • Peru 498,555
    Peru
    Confirmed: 498,555
    Active: 134,904
    Recovered: 341,938
    Death: 21,713
  • Mexico 498,380
    Mexico
    Confirmed: 498,380
    Active: 107,079
    Recovered: 336,635
    Death: 54,666
  • Chile 378,168
    Chile
    Confirmed: 378,168
    Active: 16,544
    Recovered: 351,419
    Death: 10,205
  • Spain 376,864
    Spain
    Confirmed: 376,864
    Active: 348,285
    Recovered: ?
    Death: 28,579
  • Iran 333,699
    Iran
    Confirmed: 333,699
    Active: 24,467
    Recovered: 290,244
    Death: 18,988
  • UK 313,798
    UK
    Confirmed: 313,798
    Active: 272,469
    Recovered: ?
    Death: 41,329
  • Saudi Arabia 293,037
    Saudi Arabia
    Confirmed: 293,037
    Active: 32,499
    Recovered: 257,269
    Death: 3,269
  • Pakistan 286,674
    Pakistan
    Confirmed: 286,674
    Active: 16,475
    Recovered: 264,060
    Death: 6,139
  • Bangladesh 266,498
    Bangladesh
    Confirmed: 266,498
    Active: 109,896
    Recovered: 153,089
    Death: 3,513
  • Italy 251,713
    Italy
    Confirmed: 251,713
    Active: 13,791
    Recovered: 202,697
    Death: 35,225
  • Turkey 244,392
    Turkey
    Confirmed: 244,392
    Active: 11,412
    Recovered: 227,089
    Death: 5,891
  • Germany 220,850
    Germany
    Confirmed: 220,850
    Active: 10,774
    Recovered: 200,800
    Death: 9,276
  • France 206,696
    France
    Confirmed: 206,696
    Active: 92,853
    Recovered: 83,472
    Death: 30,371
  • Canada 120,844
    Canada
    Confirmed: 120,844
    Active: 4,690
    Recovered: 107,148
    Death: 9,006
  • China 84,756
    China
    Confirmed: 84,756
    Active: 724
    Recovered: 79,398
    Death: 4,634
  • Netherlands 60,627
    Netherlands
    Confirmed: 60,627
    Active: 54,466
    Recovered: ?
    Death: 6,161
  • Australia 22,358
    Australia
    Confirmed: 22,358
    Active: 8,996
    Recovered: 13,001
    Death: 361
  • S. Korea 14,770
    S. Korea
    Confirmed: 14,770
    Active: 648
    Recovered: 13,817
    Death: 305
  • New Zealand 1,589
    New Zealand
    Confirmed: 1,589
    Active: 36
    Recovered: 1,531
    Death: 22

High-level panel formed to recommend reforms in India’s drug regulatory system

Author at TechGenyz India

A high-level committee of experts has been formed by the government to recommend reforms in India’s drug regulatory system so that approval processes can be fast-tracked.

Faced with the ominous threat of the coronavirus infection, a number of steps such as fast-tracking the approval process for drugs, research, and vaccine development were taken. A health ministry official said the aim of the panel is to identify and institutionalize these measures.

According to a recent Union Health Ministry order, the committee will study the current drug regulatory system and submit recommendations for reforms, so as to bring the system in line with global standards and make it more efficient.

“The issue of reforms in the Drug Regulatory System has been engaging the attention of the government for quite some time now.

“Although requisite procedural changes have been carried out during the COVID-19 pandemic and have worked quite well, it is felt that comprehensive changes in the drug regulatory regime should be carried out to reflect global best practices as well as domestic requirements, and to streamline Central Drugs Standard Control Organization (CDSCO) to make it more effective,” the order issued on May 11 stated.

The committee chaired by Rajesh Bhushan, the OSD to the Union health minister, comprises top drug and vaccine entrepreneurs of India along with officers nominated from the Department of Pharmaceuticals, Department of Biotechnology, Indian Pharmacopoeia Commission, Indian Pharmaceutical Alliance, ICMR along with public health expert from AIIMS.

The order stated, “While nominating a member, the ministries/ departments/ institutions should keep in mind that the officer being nominated should have a flexible approach and willing to consider far-reaching reforms with an open mind.”

India’s Joint Drug Controller Dr Eswara Reddy will assist the committee in their work on adopting global best practices. The committee, which has met twice till now, will submit its report within one month from the date of its formation.

The committee has been asked by the ministry to also study earlier reports given by the department-related Parliamentary Standing Committee on clinical trials and working of the CDSCO and address the unimplemented recommendations of the previous panels.

Career

Subscribe